2021 Global Veterinary Vaccines Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application

Description:

Growing numbers of farm and companion animals, increasing use of intensive animal husbandry practices and rising incidence of chronic diseases in animals have propelled the need for better animal healthcare.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/256345 .

Food safety concerns have boosted the usage of vaccines for better farm animal production.

The global market for veterinary vaccines is estimated to be worth $12.68 billion in 2014. Expected to grow at a CAGR of 8.84 %, the market is set to reach a value of US$19.35 billion by 2019.

Factors responsible for the growth of the market are increasing Zoonotic diseases, increasing investments by government bodies, animal welfare associations and leading players. Recent epidemics like swine flu, avian influenza and anthrax created awareness among livestock owners to avoid the huge production losses due to these diseases. The future of the animal vaccines will be dominated by DNA-related vaccine which can target the particular disease with minimal vaccines shots. Such innovative products will be more capable of providing protection than the conventional vaccines. However, rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to increasing risk of obesity and other chronic diseases are key restraints of this market. Veterinary vaccine market has shown growth in recent years which can be attributed to increasing husbandry practices and better management of farms. This results in estimation of further growth in the market due to advancement in biotechnological research.

Browse the full report @ http://www.orbisresearch.com/reports/index/global-veterinary-vaccines-market-by-disease-animal-and-region-industry-analysis-size-share-growth-trends-and-forecasts-2016-2021 .

In country wise analysis, Chinese animal vaccine market is set to grow because the R&D platform and technology has the capability to support the development of various veterinary vaccines and the expansion of governmental tender vaccine.

The global veterinary vaccine market is segmented by type of disease in companion and farm animals – poultry vaccines (Bronchitis, Avian Influenza, Marek’s disease, New castle disease), Swine vaccines (Porcine reproductive disease, Swine influenza, Swine Pneumonia). By vaccine technology, the market is segmented into toxoid vaccines, recombinant vaccines, inactivated vaccines and live attenuated vaccines.

Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/256345 .

By geography, the market is divided into North America, Asia-Pacific, Europe and the rest of world. Europe accounts for the largest share of the animal vaccines market, followed by North America. While North America and Europe have decelerated growth in veterinary vaccines due to quality safety, high maturity and other factors, developing regions like Asia-pacific and other developing countries have fast growing animal vaccine market.

Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada) are the key players in the global animal vaccines market.

COMPANY PROFILES
1 ZOETIS ANIMAL HEALTHCARE
1.1 BUSINESS OVERVIEW
1.2 FINANCIAL OVERVIEW
1.3 PRODUCTS
2 ABAXIS, INC.
2.1 BUSINESS OVERVIEW
2.2 FINANCIAL OVERVIEW
2.3 PRODUCTS
3 NEOGEN CORPORATION
3.1 BUSINESS OVERVIEW
3.2 FINANCIAL OVERVIEW
3.3 PRODUCTS
4 HESKA CORPORATION
4.1 BUSINESS OVERVIEW
4.2 FINANCIAL OVERVIEW
4.3 PRODUCTS
5 IDEXX LABORATORIES
5.1 BUSINESS OVERVIEW
5.2 FINANCIAL OVERVIEW
5.3 PRODUCTS
6 QIAGEN
1 BUSINESS OVERVIEW
2 FINANCIAL OVERVIEW
3 PRODUCTS
7 VIRBAC SA
7.1 BUSINESS OVERVIEW
7.2 FINANCIAL OVERVIEW
7.3 PRODUCTS
8 PRIONICS AG
8.1 BUSINESS OVERVIEW
8.2 FINANCIAL OVERVIEW
8.3 PRODUCTS
9 BIOCHEK
9.1 BUSINESS OVERVIEW
9.2 FINANCIAL OVERVIEW
9.3 PRODUCTS
10 IDVET
10.1 BUSINESS OVERVIEW
10.2 FINANCIAL OVERVIEW
10.3 PRODUCTS

For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +912064101019

For more information contact sales@orbisresearch.com

This release was published on openPR.